Disease Associations
Prostate cancer patients should be assessed for likelihood of gynecomastia
Published in Cancer Weekly, December 20th, 2005
According to recent research from the United States, "Gynecomastia is a potentially treatment limiting adverse event in men receiving hormone therapy for prostate cancer. In large, randomized, placebo controlled studies approximately 50% or more of patients with prostate cancer experienced gynecomastia due to multiple mechanisms. Although its severity was mostly reported as mild to moderate, gynecomastia was cited as the reason for most premature withdrawals from therapy."
"In patients with advanced forms of prostate cancer bilateral...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2005-12-20)
More Articles from Cancer Weekly
- Breast Cancer
C-MYC Asn-11-Ser polymorphism associated with increased risk for familial breast cancer - Cancer Risk Factors
Mutations in androgen receptor gene linked to risk of testicular cancer - Cancer Therapy
Downmodulation of E1A protein expression used to aid design of cancer-selective adenoviruses - Cancer Therapy
Novel aminosubstituted xanthenones overcame multidrug resistance toward MES-SA/Dx5 cells - Complementary & Alternative Medicine
Ferulic acid and vitamins C and E use protects against skin cancer - Apoptosis
Gleditsia sinensis fruit extract induced apoptosis in human carcinoma cells - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
